An international research collaboration led by Rutgers University-New Brunswick scientists that examined microscopic blobs of protein found in human cells has discovered that some morph from an almost ...

Researchers have now found initial evidence that a blood test to detect the alpha-synuclein protein is a viable, less invasive option to diagnose PD. The study appears in the Journal of Parkinson ...

A new study reveals that the protein alpha-synuclein, known for its role in Parkinson’s disease, also contributes to the ...

The study, published in the journal Science Advances, suggests new avenues for drug development to reduce the risk of ...

A new study suggests that targeting the protein alpha-synuclein could be a possible new target for treating melanoma.

A tiny protein at the center of Parkinson’s disease also plays a surprising role in melanoma, a dangerous skin cancer. New ...

In a new study published in Experimental Physiology, Surrey researchers studied mouse models and found a harmful build-up of the alpha-synuclein protein, which is associated with Parkinson's disease, ...

An international research collaboration led by Rutgers University-New Brunswick scientists that examined microscopic blobs of protein found in human ...

A small protein known for its role in brain diseases like Parkinson’s may also play a surprising role in skin cancer, ...

A small protein involved in neurodegeneration leading to Parkinson's disease also drives a type of skin cancer known as melanoma, new research led by Oregon Health & Science University finds.

AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease Active ...

"Developing drugs that target alpha-synuclein may be useful in both diseases," said senior author Vivek Unni, M.D., Ph.D., an associate professor of neurology in the OHSU School of Medicine.